ELAVL1 and inflammatory bowel disease: The progression of chronic IBD in these mice requires an interplay between innate, adaptive and tissue resident cells (4, 48–50) and as such it approximates the complexities of chronic intestinal inflammation which could be affected differently by the loss of myeloid or IEC HuR.